Current role
Biotechnology · Healthcare
Board Member
2020-12-10–present
Robert E. Conway
Board Member
Oruka Therapeutics, Inc. (ORKA)Equibles does not estimate personal net worth.
About Robert E. Conway
Robert E. Conway is recorded as Board Member at Oruka Therapeutics, Inc. (ORKA) since December 10, 2020. Oruka Therapeutics, Inc. reported in an 8-K filed January 31, 2024 that Robert E. Conway was appointed Director, effective January 30, 2024. Oruka Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Oruka Therapeutics, Inc. includes Lawrence Klein (CEO and Board Member), Thomas A. Keuer (CEO), Samarth Kulkarni (Chairman and Board Member) and 7 others.
“Dr. Michael R. Bristow and Mr. Robert E. Conway, to the Board for a three-year term ending at the 2026 Annual Meeting of Stockholders”
Affiliation history
-
Current
2020-12-10–present
Company network
Leadership on record at Oruka Therapeutics, Inc.
- Lawrence Klein CEO, Board Member
- Thomas A. Keuer CEO
- Samarth Kulkarni Chairman, Board Member
- C. Jeff Dekker CFO
- C. Jeffrey Dekker CFO
- Laura Sandler COO
- Paul Quinlan General Counsel
- Anders Hove Board Member
- Cameron Turtle Board Member
- Carl Dambkowski Board Member